Drug Shortage Report for SANDOZ-DICLOFENAC

Last updated on 2020-01-22 History
Report ID 97389
Drug Identification Number 02261960
Brand name SANDOZ-DICLOFENAC
Common or Proper name DICLOFENAC
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) DICLOFENAC SODIUM
Strength(s) 50MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 120 FCT
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2019-10-21
Estimated end date 2019-12-20
Actual end date 2019-12-10
Shortage status Resolved
Updated date 2020-01-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-01-22 French Compare
v5 2020-01-22 English Compare
v4 2019-11-18 French Compare
v3 2019-11-18 English Compare
v2 2019-10-29 French Compare
v1 2019-10-29 English Compare

Showing 1 to 6 of 6